Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology
Alternate names Федеральное государственное бюджетное учреждение "Российский научный центр рентгенорадиологии", Russian Scientific Center of Roentgenoradiology
Parent institution Ministry of Health of the Russian Federation
ROR: Yes
Works count: 763
Citations count: 11,600
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
2019 · Brian I. Rini, Elizabeth R. Plimack, et al. · New England Journal of Medicine
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial
2011 · Brian I. Rini, Bernard Escudier, et al. · The Lancet
Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial
2020 · Thomas Powles, Elizabeth R. Plimack, et al. · The Lancet Oncology